Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Validating Consensus on Post TAVR Conduction Disturbances in the Clinical Practice

Little over a year ago, JACC published the expert consensus on the management of post transcatheter aortic valve replacement (TAVR) conduction disturbances. This publication homogenized criteria and was welcomed by operators who, when in doubt, tended to prematurely indicate definite pacemaker implantation or delayed discharge in order to monitor patients. 

El consenso sobre trastornos de conducción post TAVI a prueba en la práctica clínica

These criteria, however, was nothing but expert consensus to be validated over time, especially in the daily clinical practice

This analysis was based on a registry that classified patients using the consensus algorithm: patients eligible for early discharge (1 or 2 days after TAVR); patients at high risk of high degree atrioventricular block who require additional monitoring; and patients with pacemaker indication. 

Primary end point was pacemaker implantation rate for high degree or complete block at 30 days. All patients with prior pacemaker, valve in valve or electrocardiogram were excluded. 

Of 1439 patients undergoing TAVR between 2014 and 2019, 73% were eligible for early discharge, 21% were at high risk of complete block and the remaining 6% required pacemaker implantation. 


Read also: Experts Reach Consensus on Post TAVR Pacemaker Indication.


Pacemaker implantation rate 30 days after TAVR was 16% (234 patients). 2.7% of the group eligible for early discharge finally required a pacemaker within 30 days after TAVR, and so did 41% of the high-risk group and 100% of those with pacemaker indication. 

Conclusion

The expert consensus on post TAVR conduction disturbances was able to safely identify patients needing a pacemaker. This strategy allows a more uniform management, facilitates early discharge of low-risk patients, and prevents prolonging unnecessary monitoring 3 out of 4 patients

Original Title: Validation of the 2019 Expert Consensus Algorithm for the Management of Conduction Disturbances After TAVR.

Reference: Daniel Malebranche et al. J Am Coll Cardiol Intv. 2021 May, 14 (9) 981–991.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

Beyond TAVI: Cardiac Rehabilitation as a Determinant of Clinical Outcomes

Aortic stenosis is an increasingly prevalent condition associated with population aging, with a prevalence of approximately 3.4% in individuals over 75 years of age...

Comparative outcomes between transaxillary approach and thoracotomy-based approaches in TAVI with alternative access

TAVI has become the standard treatment for high-risk aortic stenosis. When transfemoral access is not feasible (approximately 10–15%), alternative approaches are used: transaxillary (subclavian...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...